Concepedia

Edward Agura

EA

9

Publications

787

Citations

9

H-Index

1996

Active since

Affiliations

Seagen (United States)(Current)

Texas Oncology

Baylor University Medical Center

City Of Hope National Medical Center

University of Utah

Edward Agura is an author at Seagen (United States) specializing in cell transplantation, marrow transplantation, and transplantation.

Top concepts

Publications per year

1996–2018

9

Publications

9

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Ann S. LaCasce, R. Gregory Bociek, Ahmed Sawas et al. · Blood · 2018 · 246 citations · Full text

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

Craig H. Moskowitz, Jan Walewski, Auayporn Nademanee et al. · Blood · 2018 · 237 citations · Full text

The National Marrow Donor Program 20 Years of Unrelated Donor Hematopoietic Cell Transplantation

Karen K. Ballen, Roberta King, Pintip Chitphakdithai et al. · Biology of Blood and Marrow Transplantation · 2008 · 105 citations · Full text

, , +12

Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma

Ann S. LaCasce, Gregory Bociek, Ahmed Sawas et al. · Blood · 2015 · 61 citations

Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study.

C Rosenfeld, Richard F. Collins, Luis Piñeiro et al. · Journal of Clinical Oncology · 1996 · 41 citations

Rows per page

1–5 of 9